CSIMarket



Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

DGX's Capital Expenditures Growth by Quarter and Year

Quest Diagnostics Inc's Capital Expenditures results by quarter and year




DGX Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 144.00 162.00 172.00
III Quarter September - 89.00 91.00 96.00
II Quarter June - 84.00 82.00 85.00
I Quarter March 63.00 86.00 83.00 47.00
FY   63.00 403.00 418.00 400.00



DGX Capital Expenditures first quarter 2022 Y/Y Growth Comment
Quest Diagnostics Inc reported fall in Capital Expenditures in the first quarter 2022 by -26.74% to $ 63.00 millions, from the same quarter in 2021.
The drop in the first quarter 2022 Quest Diagnostics Inc's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures increase of 10.55%.

Looking into first quarter 2022 results within Medical Laboratories industry 19 other companies have achieved higher Capital Expenditures growth. While Quest Diagnostics Inc' s Capital Expenditures drop of -26.74% ranks overall at the positon no. 2210 in the first quarter 2022.




DGX Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -11.11 % -5.81 % 13.91 %
III Quarter September - -2.2 % -5.21 % -39.62 %
II Quarter June - 2.44 % -3.53 % 8.97 %
I Quarter March -26.74 % 3.61 % 76.6 % -35.62 %
FY   - -3.59 % 4.5 % -13.23 %

Financial Statements
Quest Diagnostics Inc's first quarter 2022 Capital Expenditures $ 63.00 millions DGX's Income Statement
Quest Diagnostics Inc's first quarter 2021 Capital Expenditures $ 86.00 millions Quarterly DGX's Income Statement
New: More DGX's historic Capital Expenditures Growth >>


DGX Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 61.8 % 78.02 % 79.17 %
III Quarter September - 5.95 % 10.98 % 12.94 %
II Quarter June - -2.33 % -1.2 % 80.85 %
I Quarter March -56.25 % -46.91 % -51.74 % -68.87 %
FY (Year on Year)   - -3.59 % 4.5 % -13.23 %




Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #20
Healthcare Sector #373
Overall #2210

Capital Expenditures Y/Y Growth Statistics
High Average Low
152.38 % 10.55 % -62.92 %
(Sep 30 2018)   (Dec. 31, 2012)
Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #20
Healthcare Sector #373
Overall #2210
Capital Expenditures Y/Y Growth Statistics
High Average Low
152.38 % 10.55 % -62.92 %
(Sep 30 2018)   (Dec. 31, 2012)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Quest Diagnostics Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
177.05 % 16.44 % -81.43 %
(Sep 30 2015)  


DGX's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Quest Diagnostics Inc reported fall in Capital Expenditures from the previous quarter by -56.25% to $ 63.00 millions, from $ 144.00 millions declared in the previous reporting period.

When you evaluate current downturn in the I. Quarter 2022, you must assume, that usually I. Quarter performance emerge softer relative to the forth quarter, Katherine R. White, a business expert based in London said.

Within Medical Laboratories industry 4 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Quest Diagnostics Inc's Capital Expenditures growth quarter on quarter, overall rank is 340.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #30
Overall #340
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #30
Overall #340
Capital Expenditures Q/Q Growth Statistics
High Average Low
177.05 % 16.44 % -81.43 %
(Sep 30 2015)  


DGX's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2022 Quest Diagnostics Inc reported fall in Capital Expenditures from the forth quarter by -56.25% to $ 63.00 millions, from $ 144.00 millions released a quarter before.

If you analyse recent shortcoming at the I. Quarter, you suppose to assume, that frequently I. Quarter Capital Expenditures appear to be sluggish in contrast to the preciding period

Within Medical Laboratories industry 4 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Quest Diagnostics Inc's Capital Expenditures growth quarter on quarter, overall rank is 340.


Quest Diagnostics Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Capital Expenditures 12 Months Ending $ 380.00 $ 403.00 $ 421.00 $ 423.00 $ 421.00
Y / Y Capital Expenditures Growth (TTM) -9.74 % -3.59 % -1.64 % -2.31 % -3.44 %
Year on Year Capital Expenditures Growth Overall Ranking # 316 # 2067 # 73 # 723 # 1117
Seqeuential Capital Expenditures Change (TTM) -5.71 % -4.28 % -0.47 % 0.48 % 0.72 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 349 # 2208 # 99 # 1630 # 1310




Cumulative Capital Expenditures growth Comment
Quest Diagnostics Inc's cumulative 12 months Capital Expenditures continue to decline, but on the faster rate at -9.74% year on year, at Mar 31 2022 compare to the -3.59% decrease at Dec 31 2021. If the Quest Diagnostics Inc's fiscal year would end at Mar 31 2022, annual Capital Expenditures would be $380 millions.

Within the Healthcare sector 26 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 316, from total ranking in previous quarter at 2067.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1907.54 %
40.22 %
-35.8 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 5
Healthcare Sector # 27
Overall # 316

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
2069.62 %
48.34 %
-54.11 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 27
S&P 500 # 349
Cumulative Capital Expenditures growth Comment
Quest Diagnostics Inc's cumulative 12 months Capital Expenditures continue to decline, but on the faster rate at -9.74% year on year, at Mar 31 2022 compare to the -3.59% decrease at Dec 31 2021. If the Quest Diagnostics Inc's fiscal year would end at Mar 31 2022, annual Capital Expenditures would be $380 millions.

Within the Healthcare sector 26 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 316, from total ranking in previous quarter at 2067.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1907.54 %
40.22 %
-35.8 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 5
Healthcare Sector # 27
Overall # 316

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
2069.62 %
48.34 %
-54.11 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 27
S&P 500 # 349




Other Capital Expenditures Growth
Medical Laboratories Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
DGX's Capital Expenditures Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for DGX's Competitors
Capital Expenditures Growth for Quest Diagnostics Inc's Suppliers
Capital Expenditures Growth for DGX's Customers

You may also want to know
DGX's Annual Growth Rates DGX's Profitability Ratios DGX's Asset Turnover Ratio DGX's Dividend Growth
DGX's Roe DGX's Valuation Ratios DGX's Financial Strength Ratios DGX's Dividend Payout Ratio
DGX's Roa DGX's Inventory Turnover Ratio DGX's Growth Rates DGX's Dividend Comparisons



Companies with similar Capital Expenditures decline for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2022
Novan Inc.-0.64%$ -0.642 millions
Brookdale Senior Living Inc -1.00%$ -1.003 millions
Alkermes Plc -2.44%$ -2.442 millions
Novabay Pharmaceuticals Inc -4.00%$ -4.000 millions
Shattuck Labs Inc -5.69%$ -5.686 millions
Morphic Holding inc -5.88%$ -5.882 millions
Fulcrum Therapeutics Inc -6.11%$ -6.107 millions
Vbi Vaccines Inc-7.37%$ -7.374 millions
Community Health Systems Inc -7.62%$ -7.619 millions
Sqz Biotechnologies Company-7.69%$ -7.692 millions
Tarsus Pharmaceuticals Inc -8.00%$ -8.000 millions
Inspire Medical Systems inc -8.02%$ -8.024 millions
Becton Dickinson And Company-10.28%$ -10.277 millions
Vertex Pharmaceuticals Inc-10.33%$ -10.329 millions
Xtant Medical Holdings Inc -10.70%$ -10.701 millions
Myriad Genetics Inc -11.27%$ -11.268 millions
Exact Sciences Corporation-11.33%$ -11.332 millions
Inogen Inc -11.41%$ -11.414 millions
Alphatec Holdings Inc -11.81%$ -11.808 millions
Avanos Medical Inc -12.28%$ -12.281 millions
Merck and Co Inc -13.23%$ -13.228 millions
Genocea Biosciences Inc -13.35%$ -13.345 millions
Abbvie Inc -13.83%$ -13.830 millions
Acadia Healthcare Company Inc -13.90%$ -13.897 millions
Procyon Corp-14.32%$ -14.319 millions
Ocugen Inc -14.56%$ -14.559 millions
Davita Inc -15.05%$ -15.047 millions
Biolife Solutions Inc-15.35%$ -15.349 millions
Covetrus Inc -15.38%$ -15.385 millions
Bausch Health Companies Inc -16.18%$ -16.176 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MHPC's Profile

Stock Price

MHPC's Financials

Business Description

Fundamentals

Charts & Quotes

MHPC's News

Suppliers

MHPC's Competitors

Customers & Markets

Economic Indicators

MHPC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071